Introduction
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A major well-known immunological barrier to xenotransplantation of pig organs into humans is the binding of human natural anti-Gal antibody to α-gal epitopes (Galα1-3Galβ1-4GlcNAc-R) abundantly expressed on pig cells, inducing complement activation, hyperacute rejection, and acute vascular rejection of the xenograft. 6 These findings indicate that human CD8 + CTL-mediated 55 cytotoxicity in xenograft recipients is a new immunologic barrier for successful pig-to-human xenotransplantation. In the present study, we aimed to produce transgenic pigs in which this CTLmediated response against xenograft cells is blocked, and assess the mechanism underlying direct destruction of xenograft cells by human CD8 + CTL.
Studies with mice deficient in perforin/granzyme or FasL have indicated that the 60 perforin/granzyme and FasL systems are the major pathways for CTL-mediated cytotoxicity.
7,8,9
CD8 + CTL predominantly uses the Fas/FasL pathway to kill xenografted cells. 
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One of the most remarkable research fields using miniature pigs is xenotransplantation.
Transgenic pigs have been produced for this purpose using the somatic cell nuclear transfer (SCNT)
technique. 21 Recent advances in genetic engineering technology, particularly using SCNT, has allowed the generation of genetically modified miniature pigs for the development of A previous investigation on in vivo-generated embryos reports that both placenta development
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and maintenance of pregnancy are influenced by fetal and maternal breed. 33 Here, we hypothesize that breed differences between cell donors and recipients is an important factor affecting the success of cloning of miniature pigs. 
Production of transgenic cloned pigs
Cloned miniature piglets can be produced using both miniature and domestic pig recipients
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( Table 1) . Pregnancy rates after transferring cloned miniature pig embryos into recipient pigs were higher in miniature than domestic recipients. However, delivery rates of miniature pig embryos transferred to domestic pig recipients were significantly higher than the rates of those transferred to miniature pig recipients. Domestic recipient pigs delivered one healthy female piglet and two stillborn piglets. The miniature recipient also delivered one healthy female piglet. No abnormalities
140
were observed upon initial physical examination of the piglets. The presence of the mFasL gene in individual piglets was confirmed by PCR using DNA from the umbilical cord (Fig. 3a) . Analysis of ear cells using FISH probes for the membrane-bound FasL gene revealed transgene integration in all piglets identical to that observed in metaphase spreads derived from the F4-41 cell line (Fig. 3b,c ).
Transgene expression was analyzed using FACS. Transgenic pig ear fibroblasts were prepared from 145 transgenic piglets at 30 days after birth. FACS analysis revealed a slightly lower mFasL level in transgenic piglet ear cells than in donor cells. However, we observed stable expression of mFasL (Fig. 1d ).
The 11 microsatellite markers were used for differentiating between donor cell lines as well as recipients. As shown in Table 2 , nuclear DNA genotypes were identical between the cell lines and
150
SCNT clones, but differed from those of the surrogate recipients. Our data confirm that the piglets obtained are derived from the cell lines used for SCNT.
Phenotype analysis of cultured lymphocytes
Although all subpopulations were detected among fresh lymphocytes, the majority (>80%) of 155 lymphocytes cultured for 14 days were CD8 + T cells and small amounts (<20%) were positive for the anti-CD56 antibody. B cells and macrophages were not detected among the cultured lymphocytes (Fig. 4a) . Furthermore, CD8 + CTLs present in 14-day cultures were confirmed as T cells capable of killing porcine fibroblasts following isolation using magnetic beads (Fig. 4b) . Our findings indicate that strong cytotoxicity of cultured lymphocytes is associated with the CD8 + T 160 population.
Overexpression of mFasL effectively prevents CD8 + CTL-mediated cytotoxicity against ear fibroblasts from transgenic piglet
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Freshly obtained lymphocytes from healthy donors displayed no cytotoxic activity towards normal mini-pig cells. However, cells cultured for 14 days had highly detrimental effects.
Furthermore, strong cytotoxicity against mini-pig fibroblasts was associated with CD8 Previous studies indicated that human CD8 + CTL-mediated killing by xenograft recipients
185
represents an immunological barrier because these are highly toxic to pig xenograft cells. 6 Our results additionally demonstrate activation of CD8 + CTL that directly kill xenograft target cells in vitro. Incubation of lymphocytes with pig primary cells, followed by the addition of IL-2 after 3 days, resulted in the emergence of a CD8 + T cell population comprising more than 80% of cultures incubated for 14 days (Fig. 4a) 
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(sFasL), which is functional in inducing apoptosis. Tanaka and colleagues produced mFasL by deleting the cleavage site (residues 110 to 134). 36 Upon binding of TNF to its receptor, the complex is internalized and degraded, leading to receptor downregulation. 40 The sFasL/Fas complex may be easily internalized, whereas internalization of mFasL with Fas is likely to be retarded. Our study demonstrates that transgenic cloned miniature pigs can be produced using both miniature and domestic pig recipients (Table 1) . Using miniature pig cells as nuclear donors, we obtained pregnancy rates of 16% and 35% in miniature and domestic recipient animals, respectively.
225
The production efficiency of cloned piglets using common domestic pigs as recipients tended to be higher, although no clear statistical differences were evident due to the small number of transfer experiments. In particular, miniature pig SCNT clones displayed considerably more fetal lethality at day 45 of gestation. Our findings were consistent with those of a previous study performed with Yucatan using SCNT embryos. 46 In view of resorbing around implantation periods, Yucatan SCNT transferring cloned embryos with damaged zona pellucida to the oviduct. 47 Overall, reduced efficiencies in the miniature pig are unlikely to be an issue of technical variability or oocyte or 235 recipient quality because higher efficiencies with domestic breeds using analogous oocyte sources as donors and the same recipient herd were obtained by our group. 48 Lower viability of the miniature pig is caused by factors other than experimental variability. These factors, including mitochondrial incompatibility and reduced compatibility between the miniature pig placenta and domestic uterine environment, remain to be fully characterized. According to previous studies 240 performed with Meishan and Yorkshire pigs using in vivo fertilized embryos, pregnancy rates were 12 determined by the uterine environment up to day 90 of gestation, regardless of the fetal genotype.
33,49
Recently, domestic pigs were recommended as an embryo recipient for production of cloned miniature pigs due to their ability to accommodate more fetuses. 50 Compared with common domestic pigs, miniature pigs produce fewer piglets and production costs are higher. Consequently,
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establishing a mass production system for cloned miniature pigs using IVM oocytes derived from abattoir ovaries should further accelerate the usage of miniature pigs in this field.
To our knowledge, this is the first report to describe the generation of pigs containing transgenes of membrane-bound human FasL. Overexpression of mFasL on xenograft cells leads to strong protection against human CTL killing that may subsequently control the cellular response to 250 xenografts and thus creates a window of opportunity to facilitate xenograft survival. In the present study, the SCNT technique originally developed for common domestic pigs was applied to miniature pigs, with efficient production of reconstructed embryos. Furthermore, our findings indicate both miniature and common domestic pig recipients can be effectively used for the production of transgenic cloned miniature pigs.
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